That is proof for sure that the FDA is in cahoots with big pharma, in this case GSK. There's is nothing wrong with Hikma's copy of Advair and the "issue" with the ANDA is "classified" so we won't be told the exact reason for the CLR. I'm sure Hikma's ANDA was fine and that the FDA scam-created a reason to issue the dumb CLR.